SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -33.3% | 4,593 | -13.8% | 0.00% | – |
| Q1 2022 | $6,000 | -64.7% | 5,328 | 0.0% | 0.00% | – |
| Q4 2021 | $17,000 | -29.2% | 5,328 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -17.2% | 5,328 | 0.0% | 0.00% | – |
| Q2 2021 | $29,000 | -25.6% | 5,328 | +3.5% | 0.00% | – |
| Q1 2021 | $39,000 | -79.4% | 5,148 | -70.4% | 0.00% | – |
| Q4 2020 | $189,000 | +320.0% | 17,405 | +238.7% | 0.00% | – |
| Q3 2020 | $45,000 | -38.4% | 5,139 | -24.9% | 0.00% | – |
| Q2 2020 | $73,000 | +135.5% | 6,844 | +19.8% | 0.00% | – |
| Q1 2020 | $31,000 | -36.7% | 5,713 | -20.2% | 0.00% | – |
| Q4 2019 | $49,000 | -18.3% | 7,158 | +23.6% | 0.00% | – |
| Q3 2019 | $60,000 | +30.4% | 5,791 | 0.0% | 0.00% | – |
| Q2 2019 | $46,000 | +15.0% | 5,791 | +31.0% | 0.00% | – |
| Q1 2019 | $40,000 | +100.0% | 4,420 | +21.3% | 0.00% | – |
| Q4 2018 | $20,000 | -53.5% | 3,645 | 0.0% | 0.00% | – |
| Q3 2018 | $43,000 | +16.2% | 3,645 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | +12.1% | 3,645 | +41.6% | 0.00% | – |
| Q1 2018 | $33,000 | -5.7% | 2,574 | -28.6% | 0.00% | – |
| Q4 2017 | $35,000 | -23.9% | 3,604 | +15.8% | 0.00% | – |
| Q3 2017 | $46,000 | +27.8% | 3,112 | +42.3% | 0.00% | – |
| Q2 2017 | $36,000 | +300.0% | 2,187 | +275.1% | 0.00% | – |
| Q1 2017 | $9,000 | +28.6% | 583 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | – | 583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |